Position in NTRA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$252,719
-$86,563 QoQ
Shares Held
931
-37.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#632
of 844 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $53,746,521 across 8 Diagnostics & Research names. NTRA ranks #8 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
67,484 | $33,833,778 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
14,882 | $7,834,480 | |
| 3 | A |
Agilent Technologies, Inc.
|
50,709 | $6,735,676 | |
| 4 | DHR |
Danaher Corp /De/
|
14,389 | $2,740,816 | |
| 5 | XGN |
Exagen Inc.
|
288,810 | $1,342,966 | |
| 6 | WAT |
Waters Corp /De/
|
1,628 | $610,565 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,047 | $395,521 | |
| 8 | NTRA |
Natera, Inc.
This page
|
931 | $252,719 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,719 | 931 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $339,282 | 1,481 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $238,396 | 1,481 | Shares | Sole | 2025-10-10 | |
| No filing history on record for this holder in this stock. | ||||||